نتایج جستجو برای: opioid substance

تعداد نتایج: 236027  

2014
Parul Sharma Anita Thakur

Substance abuse has become one of the major contributor to psychiatric morbidity worldwide. The pattern of substance abuse, in patients attending psychiatry OPD of IGMC, Shimla, from the years 2006 to 2008, was studied. Alcohol abuse was found to be the most prevalent, followed by that of cannabis. Opioid, sedative and inhalant abuse trends were found increase over these years.

Journal: :Frontiers in Pharmacology 2023

Opioid use disorders and overdose have become a major public health concern in recent years. U-47700, New psychoactive substances (NPS) opioid, also known as “pinky” or “pink” has been identified new threat the drug supply because of its potency abuse potential. Conjugate vaccines that can produce antibodies against target molecules emerged promising tool to treat substance disorders. Herein, w...

2015
Brittany B Dennis Monica Bawor James Paul Michael Varenbut Jeff Daiter Carolyn Plater Guillaume Pare David C Marsh Andrew Worster Dipika Desai Lehana Thabane Zainab Samaan

BACKGROUND The consequences of opioid relapse among patients being treated with opioid substitution treatment (OST) are serious and can result in abnormal cardiovascular function, overdose, and mortality. Chronic pain is a major risk factor for opioid relapse within the addiction treatment setting. There exist a number of opioid maintenance therapies including methadone, buprenorphine, naltrexo...

Journal: :Annals of internal medicine 2007
Bridget A Martell Patrick G O'Connor Robert D Kerns William C Becker Knashawn H Morales Thomas R Kosten David A Fiellin

BACKGROUND The prevalence, efficacy, and risk for addiction for persons receiving opioids for chronic back pain are unclear. PURPOSE To determine the prevalence of opioid treatment, whether opioid medications are effective, and the prevalence of substance use disorders among patients receiving opioid medications for chronic back pain. DATA SOURCES English-language studies from MEDLINE (1966...

Journal: :The Journal of pharmacology and experimental therapeutics 2004
Hsiang-En Wu Jonathan Thompson Han-Sen Sun Randy J Leitermann James M Fujimoto Leon F Tseng

Intrathecal (i.t.) pretreatment with a low dose (0.3 nmol) of morphine causes an attenuation of i.t. morphine-produced analgesia; the phenomenon has been defined as morphine-induced antianalgesia. The opioid-produced analgesia was measured with the tail-flick (TF) test in male CD-1 mice. Intrathecal pretreatment with low dose (0.3 nmol) of morphine time dependently attenuated i.t. morphine-prod...

Journal: :Canadian family physician Medecin de famille canadien 2009
Beth Sproule Bruna Brands Selina Li Laura Catz-Biro

OBJECTIVE To evaluate the clinical observation that the number of individuals seeking opioid detoxification from oxycodone was increasing at the Centre for Addiction and Mental Health (CAMH) in Toronto, Ont; and to identify the characteristics of individuals seeking opioid detoxification at CAMH. DESIGN Retrospective analysis of patient health records. SETTING Medical Withdrawal Management ...

2017
Theresa A Cassidy Natasha Oyedele Travis C Mickle Sven Guenther Simon H Budman

PURPOSE Prescriptions for hydrocodone immediate-release (IR) combination products have recently decreased, yet they represent the majority of opioid prescriptions dispensed and are commonly abused analgesics among both adults and adolescents. Little data exist to understand the contribution of IR products to the problem of prescription opioid abuse. This study aimed to better understand abuse p...

2014
Jennifer A. Klein Jennifer Ann Klein Shane Koch

Introduction Opioids have been viewed for centuries as the most effective treatment for chronic pain, yet in the past decade the misuse of prescription opioids has become a The number of prescriptions filled for opioid pain relievers—some of the most powerful medications available—has increased dramatically in recent years. From 1997 to 2007, the milligram per person use of prescription opioids...

Journal: :Addiction biology 2017
Liam J Nestor Anna Murphy John McGonigle Csaba Orban Laurence Reed Eleanor Taylor Remy Flechais Louise M Paterson Dana Smith Edward T Bullmore Karen D Ersche John Suckling Roger Tait Rebecca Elliott Bill Deakin Ilan Rabiner Anne Lingford-Hughes David J Nutt Barbara Sahakian Trevor W Robbins

There is a concerted research effort to investigate brain mechanisms underlying addiction processes that may predicate the development of new compounds for treating addiction. One target is the brain's opioid system, because of its role in the reinforcing effects of substances of abuse. Substance-dependent populations have increased numbers of the mu opioid receptor (MOR) in fronto-striatal reg...

2013
Zhong Li Huiping Zhang

BACKGROUND Polymorphisms in the μ-, δ- and κ-opioid receptor genes (OPRM1, OPRD1 and OPRK1) have been reported to be associated with substance (alcohol or drug) dependence. The influence of an individual gene on a disease trait should be more evident when analyzed in the context of gene-gene interactions. Thus, we assessed the joint effect of variants in these three opioid receptor genes on alc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید